Yung-Ming Cheng - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yung-Ming Cheng

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of Biomedical Science|November 11, 2021

Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cellsYi-Hsin Liang, Kuo-Hsing Chen, Jia-Huei Tsai, et al.

International Journal of Cancer|September 19, 2002

High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resectionJin-Tung Liang, Kuo-Chin Huang, Hong-Shiee Lai, et al.

Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 15, 2022

Ramucirumab plus triplet chemotherapy as an alternative salvage treatment for patients with metastatic colorectal cancerYi-Hsin Liang, Jin-Tung Liang, Ben-Ren Lin, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of Biomedical Science|November 11, 2021

Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cellsYi-Hsin Liang, Kuo-Hsing Chen, Jia-Huei Tsai, et al.

International Journal of Cancer|September 19, 2002

Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 15, 2022

Ramucirumab plus triplet chemotherapy as an alternative salvage treatment for patients with metastatic colorectal cancerYi-Hsin Liang, Jin-Tung Liang, Ben-Ren Lin, et al.

Pageof 2